Buprenorphine vs alpha2‐adrenergic agonists
Mean days in treatment (with varying scheduled duration) · Adults or adolescents with opioid dependence
Buprenorphine probably leads to higher mean days in treatment (with varying scheduled duration) compared with alpha2‐adrenergic agonists (moderate certainty).
1 finding from 1 review
- SMD 0.92 [0.57, 1.27]4 studies · 558 participantsModerate